Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CYCN

Cyclerion Therapeutics (CYCN)

Cyclerion Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CYCN
DateTimeSourceHeadlineSymbolCompany
06/14/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYCNCyclerion Therapeutics Inc
05/07/20244:30PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CYCNCyclerion Therapeutics Inc
01/26/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYCNCyclerion Therapeutics Inc
12/11/20235:09PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CYCNCyclerion Therapeutics Inc
12/07/20234:05PMEdgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:CYCNCyclerion Therapeutics Inc
12/04/20235:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYCNCyclerion Therapeutics Inc
12/04/20234:05PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CYCNCyclerion Therapeutics Inc
12/04/20238:00AMGlobeNewswire Inc.Cyclerion Appoints Regina Graul, Ph.D., as PresidentNASDAQ:CYCNCyclerion Therapeutics Inc
12/01/20238:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYCNCyclerion Therapeutics Inc
11/30/20236:16PMGlobeNewswire Inc.Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge InnovatorNASDAQ:CYCNCyclerion Therapeutics Inc
11/24/20231:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYCNCyclerion Therapeutics Inc
11/13/20234:30PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CYCNCyclerion Therapeutics Inc
10/23/20234:58PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYCNCyclerion Therapeutics Inc
07/31/20237:00AMGlobeNewswire Inc.Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion AssetsNASDAQ:CYCNCyclerion Therapeutics Inc
07/28/20234:48PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CYCNCyclerion Therapeutics Inc
07/19/20235:27PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYCNCyclerion Therapeutics Inc
07/12/20234:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYCNCyclerion Therapeutics Inc
06/20/20234:56PMEdgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:CYCNCyclerion Therapeutics Inc
06/09/20235:24PMEdgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:CYCNCyclerion Therapeutics Inc
06/01/20234:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCNCyclerion Therapeutics Inc
06/01/20234:00PMGlobeNewswire Inc.Cyclerion Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:CYCNCyclerion Therapeutics Inc
05/25/20234:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCNCyclerion Therapeutics Inc
05/23/20234:00PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CYCNCyclerion Therapeutics Inc
05/15/20235:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCNCyclerion Therapeutics Inc
05/15/20231:00PMGlobeNewswire Inc.Cyclerion Announces Reverse Stock SplitNASDAQ:CYCNCyclerion Therapeutics Inc
05/12/20238:40AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CYCNCyclerion Therapeutics Inc
05/12/20236:05AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYCNCyclerion Therapeutics Inc
05/11/20236:00PMGlobeNewswire Inc.Cyclerion Announces Definitive Agreement for Zagociguat and CY3018NASDAQ:CYCNCyclerion Therapeutics Inc
05/11/20236:00PMGlobeNewswire Inc.Cyclerion Announces Corporate Updates and Q1 2023 Financial ResultsNASDAQ:CYCNCyclerion Therapeutics Inc
04/03/20239:54AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCNCyclerion Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CYCN

Your Recent History

Delayed Upgrade Clock